Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $4.57 billion. The enterprise value is $4.19 billion.
Important Dates
The next estimated earnings date is Thursday, May 22, 2025, before market open.
Earnings Date | May 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 239.47 million shares outstanding. The number of shares has increased by 10.16% in one year.
Current Share Class | 239.47M |
Shares Outstanding | 239.47M |
Shares Change (YoY) | +10.16% |
Shares Change (QoQ) | +18.52% |
Owned by Insiders (%) | 2.71% |
Owned by Institutions (%) | 37.14% |
Float | 107.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 47.27 |
PS Ratio | 10.16 |
Forward PS | 9.44 |
PB Ratio | 13.58 |
P/TBV Ratio | 15.74 |
P/FCF Ratio | 37.70 |
P/OCF Ratio | 35.26 |
PEG Ratio | 3.12 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 62.02, with an EV/FCF ratio of 33.88.
EV / Earnings | n/a |
EV / Sales | 10.44 |
EV / EBITDA | 62.02 |
EV / EBIT | 73.58 |
EV / FCF | 33.88 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.03.
Current Ratio | 1.92 |
Quick Ratio | 1.79 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.15 |
Debt / FCF | 0.09 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.88% and return on invested capital (ROIC) is 17.99%.
Return on Equity (ROE) | -152.88% |
Return on Assets (ROA) | 5.81% |
Return on Invested Capital (ROIC) | 17.99% |
Return on Capital Employed (ROCE) | 14.40% |
Revenue Per Employee | $343,790 |
Profits Per Employee | -$242,508 |
Employee Count | 1,167 |
Asset Turnover | 0.66 |
Inventory Turnover | 6.63 |
Taxes
In the past 12 months, Cellebrite DI has paid $7.02 million in taxes.
Income Tax | 7.02M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.83% in the last 52 weeks. The beta is 1.52, so Cellebrite DI's price volatility has been higher than the market average.
Beta (5Y) | 1.52 |
52-Week Price Change | +72.83% |
50-Day Moving Average | 20.82 |
200-Day Moving Average | 17.94 |
Relative Strength Index (RSI) | 47.76 |
Average Volume (20 Days) | 1,235,931 |
Short Selling Information
The latest short interest is 1.28 million, so 0.53% of the outstanding shares have been sold short.
Short Interest | 1.28M |
Short Previous Month | 1.07M |
Short % of Shares Out | 0.53% |
Short % of Float | 1.19% |
Short Ratio (days to cover) | 0.54 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $401.20 million and -$283.01 million in losses. Loss per share was -$1.35.
Revenue | 401.20M |
Gross Profit | 338.61M |
Operating Income | 56.91M |
Pretax Income | -106.25M |
Net Income | -283.01M |
EBITDA | 67.51M |
EBIT | 56.91M |
Loss Per Share | -$1.35 |
Full Income Statement Balance Sheet
The company has $447.22 million in cash and $10.97 million in debt, giving a net cash position of $472.86 million or $1.97 per share.
Cash & Cash Equivalents | 447.22M |
Total Debt | 10.97M |
Net Cash | 472.86M |
Net Cash Per Share | $1.97 |
Equity (Book Value) | 336.02M |
Book Value Per Share | 1.43 |
Working Capital | 272.09M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $132.17 million and capital expenditures -$8.57 million, giving a free cash flow of $123.61 million.
Operating Cash Flow | 132.17M |
Capital Expenditures | -8.57M |
Free Cash Flow | 123.61M |
FCF Per Share | $0.52 |
Full Cash Flow Statement Margins
Gross margin is 84.40%, with operating and profit margins of 14.18% and -70.54%.
Gross Margin | 84.40% |
Operating Margin | 14.18% |
Pretax Margin | -68.79% |
Profit Margin | -70.54% |
EBITDA Margin | 16.83% |
EBIT Margin | 14.18% |
FCF Margin | 30.81% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.16% |
Shareholder Yield | -10.16% |
Earnings Yield | -6.07% |
FCF Yield | 2.65% |
Dividend Details Analyst Forecast
The average price target for Cellebrite DI is $23.43, which is 22.86% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.43 |
Price Target Difference | 22.86% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 16.47% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 5.93 and a Piotroski F-Score of 5.
Altman Z-Score | 5.93 |
Piotroski F-Score | 5 |